AptarGroup, Inc. 10-Q Summary
Business Context and Reporting Period
This filing is a Quarterly Report (Form 10-Q) for AptarGroup, Inc., covering the period ended June 30, 2000. AptarGroup is a global manufacturer of dispensing systems for the fragrance/cosmetic, pharmaceutical, food, and personal care markets. The company operates significant facilities in Europe, the U.S., and other foreign locations.
Key Financial Metrics
| Metric | Three Months Ended June 30, 2000 | Six Months Ended June 30, 2000 |
|---|---|---|
| Net Sales | $227.7 million | $445.3 million |
| Operating Income | $31.2 million | $59.8 million |
| Net Income | $17.8 million | $34.1 million |
| Diluted EPS | $0.49 | $0.93 |
| Operating Margin | 13.7% | 13.4% |
| Net Cash from Operations (6mo) | $53.1 million | |
| Capital Expenditures (6mo) | $39.9 million | |
| Total Debt (Current + Long-Term) | $280.2 million | |
| Cash and Equivalents | $36.9 million | |
| Net Debt to Capitalization | 36.4% |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 9% year-over-year for both the quarter and six-month periods. Excluding the negative impact of a stronger U.S. dollar, sales would have increased approximately 15-16%.
- Profitability: Net income rose 10% for the quarter and 11.9% for the six-month period compared to 1999. Operating income increased 10% for the quarter.
- Cost Structure: Cost of sales as a percentage of net sales remained constant at 62.2% for the quarter but improved slightly to 62.0% for the six-month period (down from 62.4% in 1999). This improvement was driven by better overhead utilization and foreign currency transaction gains, offsetting rising raw material costs.
- Working Capital: Net cash provided by operations decreased to $53.1 million from $66.3 million in the prior year, primarily due to increases in accounts receivable and inventories.
- Acquisitions: The company acquired the remaining 50% of a U.S. joint venture in Q1 2000 for approximately $2.3 million in cash and assumed $3.75 million in debt. No goodwill was recorded.
Guidance, Outlook, and Risks
- Market Outlook: Management expects demand for fragrance/cosmetic, pharmaceutical, and food dispensing systems to increase. Conversely, demand for U.S. personal care and household markets is expected to remain soft.
- Sales Guidance: Internal sales growth for the third quarter is projected to be in the 6% to 9% range, lower than the first-half growth rates.
- Capital Expenditures: Management anticipates total cash outlays for capital expenditures in 2000 to be between $85 million and $90 million.
- Tax Rate: The effective tax rate for 2000 is expected to range between 34.5% and 35.5%. A German tax law change reducing the corporate rate from 40% to 25% effective January 1, 2001, is expected to lower the company's overall effective tax rate in 2001.
- Risks: Key risks include foreign currency exchange fluctuations (significant exposure to the Euro), rising raw material costs, changes in customer spending, and the successful integration of acquisitions.
Investor Verification Checklist
- Verify the impact of the strengthening U.S. dollar on reported sales growth versus organic growth.
- Monitor raw material cost trends and their effect on future gross margins.
- Review the company's ability to maintain sales growth in the soft U.S. personal care market.
- Confirm the timeline and success of the electronic aerosol dispensing system development (Microflow acquisition).
- Track the utilization of the $75 million revolving credit facility and debt repayment schedules.